Sugar-containing beverage intake in toddlers and body composition up to age 6 years: the Generation R study

E T M Leermakers1, J F Felix2, N S Erler3

  • 11] Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands [2] The Generation R Study Group, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Insights

Early intake of sugar-containing beverages (SCBs) is linked to higher body mass index (BMI) in girls up to age six. These findings suggest limiting SCB consumption in early life is crucial for healthy childhood development.

Area of Science:

  • Pediatric Nutrition
  • Childhood Obesity Research
  • Developmental Pediatrics

Background:

  • Sugar-containing beverage (SCB) intake is linked to higher childhood body mass index (BMI).
  • The impact of SCB consumption during infancy on BMI development remains unclear.
  • This study investigates early SCB intake and its long-term effects on children's growth and body composition.

Purpose of the Study:

  • To examine the association between sugar-containing beverage (SCB) intake at 13 months of age and body mass index (BMI) development until 6 years.
  • To assess the relationship between early SCB intake and body composition at age 6 years.

Main Methods:

  • A prospective cohort study of 2371 Dutch children.
  • SCB intake assessed at 13 months using a validated Food Frequency Questionnaire.
  • BMI and body composition (Dual-energy X-ray absorptiometry) measured up to age 6 years.

Main Results:

  • Higher SCB intake at 13 months was associated with significantly higher BMI in girls at ages 2, 3, 4, and 6 years.
  • A trend towards a higher android/gynoid fat ratio was observed in girls with high SCB intake, but not overall body fat percentage.
  • No significant association was found between early SCB intake and BMI or body composition in boys; however, boys with high intake were taller at age 6.

Conclusions:

  • Increased sugar-containing beverage (SCB) intake in infancy is associated with higher BMI in girls through age 6.
  • These findings highlight that the detrimental effects of SCB consumption begin early in life.
  • Dietary recommendations to limit SCB intake should be provided early in childhood to promote healthy development.
Abstract

Related Concept Videos

Sugars as Energy Storage Molecules01:10

Sugars as Energy Storage Molecules

Sugar (a simple carbohydrate) metabolism (chemical reactions) is a classic example of the many cellular processes that use and produce energy. Living things consume sugar as a major energy source because sugar molecules have considerable energy stored within their bonds. Consumed carbohydrates have their origins in photosynthesizing organisms like plants. During photosynthesis, plants use the energy of sunlight to convert carbon dioxide gas into sugar molecules, like glucose. Because this...
10.4K
Sugars as Energy Storage Molecules01:10

Sugars as Energy Storage Molecules

4.5K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
915
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
882
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
508
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
367